Poland· PL-100493821
Glycophos
A sodium glycerophosphate product containing natrii glycerophosphas, registered in Poland by InPharm Sp. z o.o.. The same ATC class is registered in 9 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Sodium glycerophosphate is registered in 9 of 19 countries.
Countries holding a registration under ATC B05XA14 (sodium glycerophosphate), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 6 of them publish a price we can compare per daily dose
Sodium glycerophosphate · ATC B05XA14
9 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
The record
At a glance
URPL (Poland)- Active substance
- Natrii glycerophosphas
- Manufacturer
- InPharm Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- B05XA14
- ATC class
- Sodium glycerophosphate
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 3
- gtin05909991532598
- gtin05909991532604
- gtin05909991532611
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
2 interactions on record for sodium glycerophosphate.
Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Sodium glycerophosphate · interactions on record
2 records
- 2 severe
Most severe, free to view
- ErdafitinibL01EN01severe
- ErdafitinibL01EX16severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Sodium glycerophosphate in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NorwayGlycophosFresenius Kabi
- BelgiumGlycophos 20 mlFresenius Kabi
- United KingdomGlycophos 4.32g/20ml concentrate for solution for infusion vialsFresenius Kabi Ltd
- FinlandGlycophosFresenius Kabi AB
- CzechiaSODIUM GLYCEROPHOSPHATE FRESENIUSFresenius Kabi s.r.o., Praha
- FranceGLYCEROPHOSPHATE DE SODIUM KABI 216 mg/mL (1 mmol/mL), solution à diluer pour perfusionFRESENIUS KABI FRANCE
- GermanyNatriumglycerophosphat-Ampulle FreseniusFresenius Kabi Deutschland Gmbh
Authorised across Europe · EMA
The same active substance is authorised in 19 EEA countries. Names it is sold under:
- Austria · Glycophos
- Belgium · Glycophos
- Cyprus · Glycophos
- Czechia · Sodium Glycerophosphate Fresenius
- Germany · Natriumglycerophosphat-Ampulle Fresenius
- Denmark · Glycophos
- Spain · Glycophos
- Finland · Glycophos
- France · Glycerophosphate De Sodium
- Greece · Glycophos
- Hungary · Nátrium-Glicerin-Foszfát Fresenius
- Italy · Glycophos
- Lithuania · Glycophos
- Latvia · Glycophos
- Netherlands · Glycophos
- Portugal · Glycophos
- Romania · Glycophos
- Sweden · Glycophos
- Slovakia · Sodium Glycerophosphate Fresenius
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ee7ca0ee-c0d1-4f24-93b1-6eaf57b56cde GET /v1/drugs/ee7ca0ee-c0d1-4f24-93b1-6eaf57b56cde?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Koncentrat do sporządzania roztworu do infuzji",
"source": "urpl",
"strength": "216 mg/ml",
"packaging": "05909991532598 ¦ Lz ¦ 153377\n10 fiol. 20 ml\n05909991532604 ¦ Lz ¦ 153378\n10 amp. 20 ml\n05909991532611 ¦ Lz ¦ 153379\n20 amp. 20 ml",
"substance": "Natrii glycerophosphas 216 mg/ml",
"common_name": "Natrii glycerophosphas",
"pl_product_id": "100493821",
"pozwolenie_nr": "077/24",
"auth_procedure": "IR",
"authorisation_validity": "2029-02-27"
}See everything about sodium glycerophosphate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.